These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Simvor in the treatment of hyperlipoproteinaemia]. Ceska R, Kvasnicka T, Bláha V, Pit'ha J, Soska V. Vnitr Lek; 2002 Oct; 48(10):966-70. PubMed ID: 16737147 [Abstract] [Full Text] [Related]
9. [Ciprofibrate in the treatment of combined hyperlipoproteinemia. Results in more than 600 patients from 23 centers in the Czech Republic]. Ceska R, Kvasnicka T, Haas T, Soska V, Vaverková H. Vnitr Lek; 2000 Mar; 46(3):157-60. PubMed ID: 11048518 [Abstract] [Full Text] [Related]
10. [Therapeutic experiences in the treatment of hyperlipoproteinaemia with etofylline clofibrate (author's transl)]. Vorberg G, Ziegler WJ. Arzneimittelforschung; 1980 Mar; 30(11b):2068-72. PubMed ID: 7194062 [Abstract] [Full Text] [Related]
14. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia]. Ceska R, Sobra J, Kvasnicka J, Procházková R, Kvasilová M, Haas T. Cas Lek Cesk; 1996 Jul 26; 135(13):413-6. PubMed ID: 8925538 [Abstract] [Full Text] [Related]
15. Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia. Paragh G, Törocsik D, Seres I, Harangi M, Illyés L, Balogh Z, Kovács P. Curr Med Res Opin; 2004 Aug 26; 20(8):1321-7. PubMed ID: 15324535 [Abstract] [Full Text] [Related]